Premium
Pharmacokinetics of nilotinib in imatinib‐resistant/intolerant chronic myeloid leukemia patients on hemodialysis for chronic renal failure
Author(s) -
Onaka Takashi,
Takahashi Naoto,
Miura Masatomo,
Yonezawa Akihito,
Imada Kazunori,
Sawada Kenichi
Publication year - 2012
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.23125
Subject(s) - nilotinib , medicine , imatinib , myeloid leukemia , tyrosine kinase inhibitor , adverse effect , hemodialysis , gastroenterology , oncology , cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom